Linda B Piller

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Linda B Piller
    University of Texas Health Science Center at Houston, School of Public Health, Houston, TX 77030, USA
    J Clin Hypertens (Greenwich) 8:649-56; quiz 657-8. 2006
  2. ncbi Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Linda B Piller
    University of Texas School of Public Health, Houston, TX 77030, USA
    Circulation 124:1811-8. 2011
  3. ncbi Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Barry R Davis
    The University of Texas School of Public Health, Houston, TX 77030, USA
    Circulation 113:2201-10. 2006
  4. ncbi Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project
    L Kay Bartholomew
    University of Texas Health Science Center Houston, School of Public Health, Houston, TX, USA
    Clin Trials 6:329-43. 2009
  5. ncbi Comparison of the global statistical test and composite outcome for secondary analyses of multiple coronary heart disease outcomes
    Sarah Baraniuk
    Division of Biostatistics, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA
    Prog Cardiovasc Dis 54:357-61. 2012
  6. ncbi CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women
    Hung N Luu
    Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA
    J Infect Dis 205:578-85. 2012
  7. ncbi Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Vasilios Papademetriou
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    J Clin Hypertens (Greenwich) 5:377-84. 2003
  8. ncbi The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892 7936, USA
    Am Heart J 153:42-53. 2007
  9. ncbi Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Karen L Margolis
    HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440 1524, USA
    Hypertension 50:854-61. 2007

Detail Information

Publications9

  1. ncbi Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Linda B Piller
    University of Texas Health Science Center at Houston, School of Public Health, Houston, TX 77030, USA
    J Clin Hypertens (Greenwich) 8:649-56; quiz 657-8. 2006
    ..One patient died following an angioedema episode. The occurrence of angioedema in the angiotensin-converting enzyme inhibitor arm corresponds with previously reported angioedema-angiotensin-converting enzyme inhibitor associations...
  2. ncbi Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Linda B Piller
    University of Texas School of Public Health, Houston, TX 77030, USA
    Circulation 124:1811-8. 2011
    ..After the randomized phase of the trial ended in 2002, outcomes were determined from administrative databases...
  3. ncbi Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    Barry R Davis
    The University of Texas School of Public Health, Houston, TX 77030, USA
    Circulation 113:2201-10. 2006
    ..The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) stipulated assessment of the relative effect of chlorthalidone, lisinopril, and amlodipine in preventing HF...
  4. ncbi Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project
    L Kay Bartholomew
    University of Texas Health Science Center Houston, School of Public Health, Houston, TX, USA
    Clin Trials 6:329-43. 2009
    ..Conventional dissemination of clinical trial results has inconsistent impact on physician practices. A more comprehensive plan to influence determinants of prescribing practices is warranted...
  5. ncbi Comparison of the global statistical test and composite outcome for secondary analyses of multiple coronary heart disease outcomes
    Sarah Baraniuk
    Division of Biostatistics, The University of Texas Health Science Center at Houston School of Public Health, Houston, TX, USA
    Prog Cardiovasc Dis 54:357-61. 2012
    ..Data from the cardiovascular clinical trial Systolic Hypertension in the Elderly Population are used as an example...
  6. ncbi CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women
    Hung N Luu
    Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA
    J Infect Dis 205:578-85. 2012
    ..This study examined whether CD4(+) count and HIV load predict the size of the largest anal warts in 976 HIV-infected women in an ongoing cohort...
  7. ncbi Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Vasilios Papademetriou
    Veterans Affairs Medical Center, Washington, DC 20422, USA
    J Clin Hypertens (Greenwich) 5:377-84. 2003
    ..The success of the randomization of this large, diverse population and the differences in the lipid distributions among its subgroups will allow further understanding of optimal lipid-lowering treatment...
  8. ncbi The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892 7936, USA
    Am Heart J 153:42-53. 2007
    ..However, questions have been raised regarding the validity of the HF diagnosis...
  9. ncbi Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Karen L Margolis
    HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440 1524, USA
    Hypertension 50:854-61. 2007
    ....